Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jordana Fein (NPI 1841463098)

Field	Value
Entity Type	Individual
Organization	Jordana Fein
Address	10530 Linden Lake Plz Ste 305
City	Manassas
State	VA
ZIP	20109
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 9, 2008

Payer Source	Total Paid
Medicare	$4.2M
Medicaid	$0

Key Findings

JORDANA FEIN is a retina specialist in Manassas, VA with an NPI enumerated 2008-04-09 (~18 years ago). Her lifetime Medicare revenue is $4.2M and there is no Medicaid billing on file, so the provider’s measurable payer exposure in these datasets is effectively single-payer Medicare. This tenure and revenue scale are consistent with an established, Medicare-focused retina practice.

Revenue concentration is very high: the precomputed top 3 Medicare codes account for 68.3% of this provider's total Medicare revenue. Those top codes are J0178 (40.8% of this provider's total Medicare revenue), J2777 (17.1%), and J3590 (10.3%), indicating most Medicare dollars flow from a narrow set of biologic/injection-related codes.

The code mix indicates a procedure- and injection-centered retina practice: J0178 (aflibercept) shows 2.4K claims, $693 avg paid/claim, $1.7M revenue (40.8% of this provider's total Medicare revenue) and J2777 (faricimab) shows 24.5K claims, $29 avg paid/claim, $709.9K revenue (17.1%). Together with intravitreal drug codes J3590 and J3490, and procedure 67028 (2K claims, $214.4K revenue, 5.2%), the dataset documents heavy use of in-office intravitreal injections and related retinal procedures.

Competitive standing for the top revenue-driving biologics is above median but not dominant nationally: J0178 ranks #340 of 3204 providers (89th percentile; typical, unremarkable volume), J2777 ranks #401 of 2039 providers (80th percentile; typical, unremarkable volume), and J3590 ranks #199 of 631 providers (68th percentile; typical, unremarkable volume). These rankings indicate stronger-than-average activity for these drugs compared with peers, but not extreme market dominance.

Several codes show statistically high or extreme utilization relative to national peers, suggesting this provider functions as a high-volume diagnostic and treatment center. 92014 is an extreme outlier (2.4K claims, $249.6K revenue, ranks #137 of 35415 providers; 100th percentile), 92134 is also an extreme outlier (2.7K claims, $93K revenue, ranks #528 of 26868 providers; 98th percentile), and 92202 (1.6K claims, $21.1K revenue) ranks #68 of 2327 providers (97th percentile). These patterns point to unusually high comprehensive exam and retinal imaging volumes for a single provider.

Specific procedural/injectable codes are notably elevated versus peers in particular areas: J7312 (dexamethasone implant) generated $94K (595 claims) and ranks #26 of 492 providers (95th percentile; notably above typical), and 67028 shows 2K claims and $214.4K revenue (5.2% of Medicare revenue) with a national rank of #379 of 4255 (91th percentile). This suggests a substantive practice emphasis on both implantable therapies and intravitreal injection procedures.

The broader drug mix includes newer agents and biosimilars—J2778, J2781, Q5128, and J9035 appear in the top codes—indicating use of a range of anti-VEGF and other intravitreal therapeutics in addition to aflibercept. While each of these contributes smaller shares individually (for example, J2778 accounts for $110.7K or 2.7% of Medicare revenue), their presence shows therapeutic breadth that likely supports referral and complex retina care.

From a business-risk and network strategy perspective, reliance on Medicare ($4.2M lifetime Medicare revenue and no Medicaid billing on file) and on a concentrated set of injection/drug codes (top 3 = 68.3% of Medicare revenue) makes the practice sensitive to changes in drug utilization patterns or reimbursement for intravitreal biologics. At the same time, the provider’s extreme outlier status on exam and imaging codes suggests a defensible local role as a high-volume retina service provider and likely referral destination for advanced diagnostic imaging and injection management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,440	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	24,480	$30	$709.9K
J3590	Unclassified biologics	180	$2,450	$428.4K
J3490	Unclassified drugs	160	$1,820	$291.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,420	$100	$249.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,040	$110	$214.4K
J2778	Injection, ranibizumab, 0.1 mg	590	$190	$110.7K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	800	$120	$95.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	600	$160	$94K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,740	$30	$93K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Jordana Fein — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	22	80	1,400	$690	$1.1M
J2777	15	60	13,200	$30	$517.1K
J2778	17	40	560	$180	$171.5K
J3590	2	20	40	$2,290	$126K
67028	17	90	1,000	$90	$107.1K
J2781	6	20	560	$120	$86.6K
Q5128	4	10	190	$220	$70.7K
J7312	1	20	240	$160	$42.5K
92014	14	870	170	$80	$32.8K
66821	229	230	60	$210	$23K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jordana Fein, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Eric Weichel	MD	Ophthalmology Physician	$4.1M	$0
Gayatri Reilly	MD	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sundeep Kasi	VA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Jordana Fein, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prince William County Community Services Board	VA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$42.8M
Therapeutic Alliance LLC	VA	Community/Behavioral Health Agency	$0	$33.7M
Virginia Support Services, P.C.	VA	Mental Health Counselor	$0	$17.7M
Bridging The Gap Family Services	VA	Community/Behavioral Health Agency	$0	$9.1M
Virginia Home Based Counseling	VA	Mental Health Counselor	$0	$9M
Prince William County Early Intervention Program	VA	Rehabilitation Clinic/Center	$0	$8.3M
Notal Vision Inc	VA	Physiological Laboratory	$3M	$1.9K
Mohsen Ghafouri	VA	Rheumatology Physician	$2.6M	$0
Aec Medical Transport & Rapid Response LLC	VA	Land Ambulance	$1.2M	$1M
Behdad Aryavand	VA	Vascular Surgery Physician	$1.6M	$0

Jordana Fein — Billing Profile & Reimbursement Data

Sign up for Jordana Fein — Billing Profile & Reimbursement Data policy alerts

Jordana Fein — Billing Profile & Reimbursement Data

Sign up for Jordana Fein — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References